- Home
- MMM vs BMY Comparison
MMM vs BMY Comparison
Compare MMM & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MMM | BMY |
|---|---|---|
| Founded | 1902 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.6B | 113.5B |
| IPO Year | 2006 | 2006 |
Fundamental Metrics
Financial Performance| Metric | MMM | BMY |
|---|---|---|
| Price | $183.79 | $63.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 15 |
| Target Price | ★ $170.88 | $61.73 |
| AVG Volume (30 Days) | 3.0M | ★ 12.3M |
| Earning Date | 04-21-2026 | 04-30-2026 |
| Dividend Yield | 2.17% | ★ 4.38% |
| EPS Growth | N/A | ★ 178.46 |
| EPS | ★ 3.01 | 2.93 |
| Revenue | $24,948,000,000.00 | ★ $48,194,000,000.00 |
| Revenue This Year | $1.78 | N/A |
| Revenue Next Year | $3.17 | N/A |
| P/E Ratio | $60.84 | ★ $21.71 |
| Revenue Growth | ★ 1.52 | N/A |
| 52 Week Low | $139.34 | $42.52 |
| 52 Week High | $184.90 | $68.10 |
Technical Indicators
Market Signals| Indicator | MMM | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 70.39 | 58.10 |
| Support Level | $160.83 | $56.46 |
| Resistance Level | $184.90 | $68.10 |
| Average True Range (ATR) | 3.86 | 1.81 |
| MACD | 0.32 | -0.18 |
| Stochastic Oscillator | 96.05 | 34.08 |
Price Performance
Historical ComparisonAbout MMM 3M Company
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.